Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    RENX.L Gross Margin

    As of 2025-05-20, the Gross Margin of Renalytix PLC (RENX.L) is 9.3%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    RENX.L Gross Margin - Historical Value
    DateValue
    2024-06-30 9.3%
    2023-06-30 20.6%
    2022-06-30 30.9%
    2021-06-30 46.1%
    2020-06-30 -
    2019-06-30 -
    2018-06-30 -
    -
    -
    -
    RENX.L Gross Margin - Peers Comparison
    TickerNameValue
    ALMDT.PAMedian Technologies SA104.5%
    AV.MIAntares Vision SpA56.8%
    CARA.OLCarasent ASA81.1%
    CGM.PACegedim SA20.1%
    COG.LCambridge Cognition Holdings PLC79.9%
    CONTX.OLContextVision AB97.4%
    COP.DECompuGroup Medical SE & Co KgaA83.8%
    CRW.LCraneware PLC85.7%
    CSAM.OLCsam Health Group AS90.9%
    EMIS.LEMIS Group PLC92.6%
    FDBK.LFeedback PLC93.3%
    FRISQ.STFrisq Holding AB (publ)17233.7%
    GPI.MIGPI SpA71.3%
    INHC.LInduction Healthcare Group PLC78.4%
    INS.LInstem PLC96.3%
    IQAI.LIQ-AI Ltd98.1%
    IS8.DEIfa Systems AG90.4%
    M3V.DEMevis Medical Solutions AG96%
    MDA.WAMedapp SA34.8%
    MNTC.STMentice AB88.6%
    NHNantHealth Inc57%
    NXU.DENexus AG85.3%
    PHA.PAPharmagest Interactive SA69.5%
    PSKY.OLPatientsky Group AS8458%
    SDT.PAVisiodent SA51.7%
    SENS.LSensyne Health PLC65%
    SLPSimulations Plus Inc61.6%
    SNT.WASynektik SA30.5%
    Tickers added to watchlist